Physician profile
Todd M Sheperd
NPI 1679597785
$530.72
in general payments reported to CMS, 2019-2025
13 companies · $30.08 in 2025
The $30.08 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.49 · 2020: $167 · 2021: $11.75 · 2023: $172 · 2024: $102 · 2025: $30.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234 · Education: $70.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.22 |
| Education | $70.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $153.74 | 2019-2023 | |
| Salvin Dental Specialties, INC. | $128.57 | 2020 | |
| Abbott Laboratories | $70.01 | 2024 | Alinity M |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.33 | 2023 | Jardiance |
| Glaxosmithkline, LLC. | $24.38 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.98 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $17.31 | 2024 | Capvaxive, Gardasil 9, Gardasil |
| Novo Nordisk INC | $16.22 | 2025 | Rybelsus, Ozempic |
| Ironshore Pharmaceuticals INC. | $15.88 | 2020 | |
| Baxter Healthcare | $14.60 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Abbvie INC. | $13.86 | 2025 | |
| Astellas Pharma US INC | $12.27 | 2019 | |
| Esperion Therapeutics, INC. | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Sheperd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.